Disease on EC 2.3.2.B8 - E2:E3 ubiquitin transferase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Amyotrophic Lateral Sclerosis
Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.
Angelman Syndrome
Subcellular organization of UBE3A in neurons.
Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
Zn-binding AZUL domain of human ubiquitin protein ligase Ube3A.
Autoimmune Diseases
A sesquiterpene lactone from a medicinal herb inhibits proinflammatory activity of TNF-? by inhibiting ubiquitin-conjugating enzyme UbcH5.
E3 ubiquitin-protein ligase TRIM21-mediated lysine capture by UBE2E1 reveals substrate-targeting mode of a ubiquitin-conjugating E2.
Breast Neoplasms
Aberrant recombination and repair during immunoglobulin class switching in BRCA1-deficient human B cells.
KSP inhibitor SB743921 inhibits growth and induces apoptosis of breast cancer cells by regulating p53, Bcl-2, and DTL.
Carcinogenesis
Constitutional Translocation Breakpoint Mapping by Genome-wide Paired-end Sequencing Identifies HACE1 as a Putative Wilms Tumor Susceptibility Gene.
HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.
NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Cholangiocarcinoma
XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells.
Dementia
Identification of prefrontal cortex protein alterations in Alzheimer's disease.
Dyskinesias
L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor.
Fanconi Anemia
Aberrant recombination and repair during immunoglobulin class switching in BRCA1-deficient human B cells.
Glioma
Ectopic expression of E3 ubiquitin-protein ligase 2 in glioma and enhances resistance to apoptosis through activating nuclear factor ?-light-chain-enhancer of B cells.
Infections
HACE1, an E3 ubiquitin-protein ligase, Mitigates Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Infection Induced Oxidative Stress by Promoting Nrf2 Activity.
Intellectual Disability
Erratum to: Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features.
Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features.
Language Development Disorders
Erratum to: Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features.
Haploinsufficiency of the E3 ubiquitin-protein ligase gene TRIP12 causes intellectual disability with or without autism spectrum disorders, speech delay, and dysmorphic features.
Liver Cirrhosis
[Effects of bone morphogenetic protein-7 therapy on E3 ubiquitin ligase expression in mouse liver with experimentally induced fibrosis].
Lung Neoplasms
Effects of RING-SH2Grb², a Chimeric Protein Containing the E3 Ligase Domain of Cbl, on the EGFR Pathway.
Lymphoma
E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
Effects of RING-SH2Grb², a Chimeric Protein Containing the E3 Ligase Domain of Cbl, on the EGFR Pathway.
The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
Motor Neuron Disease
Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.
Muscular Atrophy
Small Molecular Weight Soybean Protein-Derived Peptides Nutriment Attenuates Rat Burn Injury-Induced Muscle Atrophy by Modulation of Ubiquitin-Proteasome System and Autophagy Signaling Pathway.
Neoplasms
A HECT E3 ubiquitin-protein ligase with sequence similarity to E6AP does not target p53 for degradation in the softshell clam (Mya arenaria).
Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.
hace1 Influences zebrafish cardiac development via ROS-dependent mechanisms.
HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response.
HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases.
Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.
MiR-30 Family Potentially Targeting PI3K-SIAH2 Predicted Interaction Network Represents a Novel Putative Theranostic Panel in Non-small Cell Lung Cancer.
Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.
NEDD4 promotes cell growth and migration via PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
Pathogen-associated molecular patterns activate expression of genes involved in cell proliferation, immunity and detoxification in the amebocyte-producing organ of the snail Biomphalaria glabrata.
Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5.
The effects of curcumin on proliferation, apoptosis, invasion, and NEDD4 expression in pancreatic cancer.
The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation.
The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity.
Papilloma
Zn-binding AZUL domain of human ubiquitin protein ligase Ube3A.
Parkinson Disease
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.
Parkin depletion delays motor decline dose-dependently without overtly affecting neuropathology in ?-synuclein transgenic mice.
Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-? hydroxysteroid dehydrogenase type 10.
Parkin Protects Against Misfolded SOD1 Toxicity by Promoting Its Aggresome Formation and Autophagic Clearance.
Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells.
Parkinsonian Disorders
14-3-3eta is a novel regulator of parkin ubiquitin ligase.
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity.
The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
Ultrastructural localization of parkin in the rat brainstem, thalamus and basal ganglia.
Retinoblastoma
Function of cell-cycle regulators in predicting silent pituitary adenoma progression following surgical resection.
Spinocerebellar Ataxias
Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.
Tauopathies
S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt/Ca+2 signaling in the P301S mouse model of tauopathy.
Virus Diseases
Zn-binding AZUL domain of human ubiquitin protein ligase Ube3A.
Wilms Tumor
Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.